VICTORIA KOTTMAN: Open Payments
NPI 1972513299 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 12 payments from 7 companies in 2025. Trend: 2023 $510 · 2024 $132 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $140 |
| Neurocrine BioSciences, Inc. | 2 | $104 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Alkermes, Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $17 |
Products named: CAPLYTA, INGREZZA, AUSTEDO XR, ARISTADA, COBENFY, REXULTI, UZEDY, VRAYLAR.
Industry payments across OH — which companies pay providers there.
